India Imports 80% Of Its Requirement Of Medical Devices: MoS Ashwini Choubey

New Delhi : (PTI) India currently imports approximately 80 per cent of its requirement of medical devices, with the US, Germany, China, Singapore and Netherlands being top exporters of such devices to the country, the Lok Sabha was informed on Friday in reference to unstarred question No. 1945.

The Central Drugs Standard Control Organisation (CDSCO) is presently regulating 28 categories of notified medical devices under the provisions of the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017, said Minister of State for Health Ashwini Choubey in a written reply.

Further, in order to regulate all medical devices, the health ministry has issued a notification dated February 11, defining medical devices and specifying mechanism for regulation of all non-notified medical devices in a phased manner to ensure quality, safety and performance of these devices, he said.

Asked if the government has set up a roadmap for India’s self-reliance in medical equipment, medical devices and medical lab kit sector, the minister said various schemes have been formulated to promote domestic manufacturing of medical devices/equipments and attract large investment in the sector.

Such schemes/initiatives are the National Biopharma Mission, DBT-AMTZ COMManD (COVID-19 Medtech Manufacturing Development) Consortia launched by the Department of Biotechnology with Andhra Pradesh Med-tech Zone (AMTZ), Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices and Scheme for Promotion of Medical Devices Parks.

A scheme called ‘Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices’ has been approved by the Centre with a total financial outlay of Rs 3,420 crore.

Another scheme ‘Promotion of Medical Device Parks’ has also been approved by the government with a financial outlay of Rs 400 crore. The National Biopharma Mission, with an outlay of Rs 148.79 crore is meant for establishment of infrastructure and facilities for manufacturing and testing of medical devices. Nine such facilities have been funded and Rs 105.42 crore have been utilized, he added.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert